Article

Technologies for glaucoma diagnosis and follow up

Early detection of glaucoma is critical. According to the AGIS study, by the time a reproducible visual field defect is detected, 20% to 50% of the retinal nerve fiber layer (RNFL) can be damaged, said Remo Susanna, Jr., MD, at the World Ophthalmology Congress on Wednesday.

Early detection of glaucoma is critical. According to the AGIS study, by the time a reproducible visual field defect is detected, 20% to 50% of the retinal nerve fiber layer (RNFL) can be damaged, said Remo Susanna, Jr., MD, at the World Ophthalmology Congress on Wednesday.

A number of imaging technologies are available to detect structural changes, but they should not replace or overshadow the importance of optic disc photos and intraocular pressure (IOP) measurements as primary diagnostic tools. Dr. Susanna is from the University of São Paulo, Brazil.

"Digital imaging devices have a role in enhancing and facilitating the assessment, as stated by the AIGS consensus in 2003," explained Dr. Susanna. "Methods like HRT, Gdx, or the frequency-doubling test may help to confirm the correctness of the diagnosis, but they should always be correlated to the appearance of the optic nerve to avoid any misleading data."

Dr. Susanna added that more experience and study is needed to validate the clinical use of these technologies.

Related Videos
AAO 2024: Matt Giegengack, MD: Injectable endothelial cell therapy shows promise for improving vision and reducing glare in corneal edema
EyeCon 2024: Adam Wenick, MD, talks about myopic interventions across the lifespan
Adam Wenick, MD, chairs EyeCon session: New treatments in geographic atrophy from detection to intervention
EyeCon 2024: Laura M. Periman, MD, shares her passion for dry eye disease, discussing her surprising discovery of the Alpenglow Sign in Demodex blepharitis
David Eichenbaum, MD, presents advances in AMD therapy, highlights different mechanisms with a common goal
Cochair Kelly K. Nichols, OD, PhD, MPH, FAAO, highlights her passion for dry eye research and the vital collaboration between ophthalmology and optometry
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
© 2024 MJH Life Sciences

All rights reserved.